These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 33014142

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A Mobile App for Identifying Individuals With Undiagnosed Diabetes and Prediabetes and for Promoting Behavior Change: 2-Year Prospective Study.
    Leung AY, Xu XY, Chau PH, Yu YTE, Cheung MK, Wong CK, Fong DY, Wong JY, Lam CL.
    JMIR Mhealth Uhealth; 2018 May 24; 6(5):e10662. PubMed ID: 29793901
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Prevalence of diabetes and predictions of its risks using anthropometric measures in southwest rural areas of China.
    Zhao X, Zhu X, Zhang H, Zhao W, Li J, Shu Y, Li S, Yang M, Cai L, Zhou J, Li Y.
    BMC Public Health; 2012 Sep 24; 12():821. PubMed ID: 22998969
    [Abstract] [Full Text] [Related]

  • 26. Predicting type 2 diabetes mellitus among fishermen in Cape Coast: a comparison between the FINDRISC score and the metabolic syndrome.
    Ephraim RKD, Owusu VB, Asiamah J, Mills A, Abaka-Yawson A, Kpene GE, Kwadzokpui PK, Adusei S.
    J Diabetes Metab Disord; 2020 Dec 24; 19(2):1317-1324. PubMed ID: 33520838
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Validation of the FINDRISC (FINnish Diabetes RIsk SCore) for prediction of the risk of type 2 diabetes in a population of southern Spain. Pizarra Study].
    Soriguer F, Valdés S, Tapia MJ, Esteva I, Ruiz de Adana MS, Almaraz MC, Morcillo S, García Fuentes E, Rodríguez F, Rojo-Martinez G.
    Med Clin (Barc); 2012 Apr 14; 138(9):371-6. PubMed ID: 21939990
    [Abstract] [Full Text] [Related]

  • 29. Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study.
    Hellgren MI, Petzold M, Björkelund C, Wedel H, Jansson PA, Lindblad U.
    Diabet Med; 2012 Dec 14; 29(12):1501-5. PubMed ID: 22443428
    [Abstract] [Full Text] [Related]

  • 30. Identification of undiagnosed type 2 diabetic individuals by the finnish diabetes risk score and biochemical and genetic markers: a population-based study of 7232 Finnish men.
    Wang J, Stancáková A, Kuusisto J, Laakso M.
    J Clin Endocrinol Metab; 2010 Aug 14; 95(8):3858-62. PubMed ID: 20463095
    [Abstract] [Full Text] [Related]

  • 31. A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population.
    Bergmann A, Li J, Wang L, Schulze J, Bornstein SR, Schwarz PE.
    Horm Metab Res; 2007 Sep 14; 39(9):677-82. PubMed ID: 17846976
    [Abstract] [Full Text] [Related]

  • 32. Gender differences in adiponectin and low-grade inflammation among individuals with normal glucose tolerance, prediabetes, and type 2 diabetes.
    Saltevo J, Kautiainen H, Vanhala M.
    Gend Med; 2009 Sep 14; 6(3):463-70. PubMed ID: 19850242
    [Abstract] [Full Text] [Related]

  • 33. Neck Circumference and its Correlation to Other Anthropometric Parameters and Finnish Diabetes Risk Score (FINDRISC).
    Volaco A, Martins CM, Soares JQ, Cavalcanti AM, Moyses ST, Filho RP, Baena CP, Precoma DB.
    Curr Diabetes Rev; 2018 Sep 14; 14(5):464-471. PubMed ID: 28969558
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The lipid accumulation product is a powerful tool to predict metabolic syndrome in undiagnosed Brazilian adults.
    Nascimento-Ferreira MV, Rendo-Urteaga T, Vilanova-Campelo RC, Carvalho HB, da Paz Oliveira G, Paes Landim MB, Torres-Leal FL.
    Clin Nutr; 2017 Dec 14; 36(6):1693-1700. PubMed ID: 28081980
    [Abstract] [Full Text] [Related]

  • 36. Screening for dysglycaemia by oral glucose tolerance test should be recommended in all women with polycystic ovary syndrome.
    Li HW, Lam KS, Tam S, Lee VC, Yeung TW, Cheung PT, Yeung WS, Ho PC, Ng EH.
    Hum Reprod; 2015 Sep 14; 30(9):2178-83. PubMed ID: 26202923
    [Abstract] [Full Text] [Related]

  • 37. Validation of the Finnish Diabetes Risk Score (FINDRISC) questionnaire for undiagnosed type 2 diabetes screening in the Slovenian working population.
    Štiglic G, Fijačko N, Stožer A, Sheikh A, Pajnkihar M.
    Diabetes Res Clin Pract; 2016 Oct 14; 120():194-7. PubMed ID: 27592167
    [Abstract] [Full Text] [Related]

  • 38. Screening for prediabetes and risk of periodontal disease.
    Salmerón D, Gómez García F, Pons-Fuster E, Pérez-Sayáns M, Lorenzo-Pouso AI, López-Jornet P.
    Diabetes Metab Syndr; 2019 Oct 14; 13(2):1661-1666. PubMed ID: 31336538
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study.
    Franciosi M, De Berardis G, Rossi MC, Sacco M, Belfiglio M, Pellegrini F, Tognoni G, Valentini M, Nicolucci A.
    Diabetes Care; 2005 May 14; 28(5):1187-94. PubMed ID: 15855587
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.